Unicycive Therapeutics In...
0.66
-0.00 (-0.17%)
At close: Jan 15, 2025, 9:30 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 675.00K 951.00K n/a n/a n/a n/a
Cost of Revenue n/a 7.00K 1K n/a n/a n/a
Gross Profit 675.00K 944.00K -1K n/a n/a n/a
Operating Income -20.77M -18.05M -8.98M -2.02M -1.96M -952.00K
Interest Income 615.00K 6.00K 628.00K 244.00K 139.00K 168.00K
Pretax Income -30.54M -18.06M -10.02M -2.26M -2.17M -1.12M
Net Income -30.54M -18.06M -10.63M -2.51M -2.30M -1.12M
Selling & General & Admin 8.55M 6.57M 2.90M 1.00M 1.17M 608.00K
Research & Development 12.90M 12.44M 6.08M 1.01M 795.00K 344.00K
Other Expenses n/a n/a n/a n/a n/a n/a
Operating Expenses 21.45M 19.00M 8.98M 2.02M 1.96M 952.00K
Interest Expense 82.00K 6.00K 628.00K 244.00K 139.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 21.45M 19.00M 8.98M 2.02M 1.96M 952.00K
Income Tax n/a 6.00K 615.00K 244.00K 139.00K -952.00K
Shares Outstanding (Basic) 24.54M 15.06M 15.00M 15.25M 8.43M 7.94M
Shares Outstanding (Diluted) 24.54M 15.06M 15.00M 15.25M 8.47M 7.94M
EPS (Basic) -1.28 -1.2 -0.71 -0.16 -0.27 -0.14
EPS (Diluted) -1.28 -1.2 -0.71 -0.16 -0.27 -0.14
EBITDA -30.18M -18.05M -8.98M n/a -63.00K n/a
Depreciation & Amortization 284.00K 7.00K 1K 2.02M 1.96M 952.00K